Skip to content

Comparison of Fixation Suture Type in Glaucoma Surgery

Comparison of Effectiveness and Safety of Eye Fixation Types During Combined Glaucoma Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03797846
Enrollment
41
Registered
2019-01-09
Start date
2018-01-01
Completion date
2019-06-01
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Glaucoma Eye

Keywords

ptosis, combined procedures, glaucoma, post-surgery complication

Brief summary

The aim of the study is to compare the effectiveness and safety of two types of intraoperative eye fixation: for the superior rectus muscle and traction suture in the peripheral cornea. This is a prospective randomized trial with a 6 month follow-up period, which covers patients with open angle glaucoma qualified for combined glaucoma procedure (phacotrabeculectomy). In I group, the intraoperatively fixation in the peripheral part of the cornea is used, in II group the bridle suture for the superior rectus muscle is performed.

Detailed description

The way of the intraoperatively fixation may have some impact for postoperative results of the level of intraocular pressure (IOP), visual acuity (BCVA) and the incidence of upper eyelid ptosis was determined as a post-operative MRD (margin reflex distance) ≥2mm.

Interventions

combined procedure with trabeculectomy and cataract removal

Sponsors

Medical University of Bialystok
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A prospective randomized trial with a 6 month follow-up period

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* co-existing glaucoma and cataract (NC1, NC2) classified by means of the LOCS III scale (Lens Opacities Classification System III) * primary open-angle glaucoma and secondary pseudoexfoliative glaucoma, in which a satisfactory IOP level was not achieved despite maximum tolerable hypotensive treatment, both topical and systemic * documented progression of loss of field of vision * significant daily IOP fluctuations * no cooperation from patient with regard to application of anti-glaucoma treatment, allergy to topical medications

Exclusion criteria

* no consent to participation in the study * prior surgical and laser procedures in the area of the eye * narrow- or closed-angle glaucoma * post-inflammatory or post-traumatic secondary glaucoma * chronic illness of the cornea or optic nerve * advanced macular degeneration * active inflammatory process * pregnancy * systemic steroid therapy

Design outcomes

Primary

MeasureTime frameDescription
IOPbaseline and twelve months after surgerythe change in the level of intraocular pressure

Secondary

MeasureTime frameDescription
BCVAbaseline and twelve months after surgerythe change in the best corrected visual acuity
MRDbaseline and twelve months after surgerythe incidence of upper eyelid ptosis determined as a post-operative MRD (margin reflex distance) ≥2mm

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026